New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support ...

Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

The real “commercial launch” happens years before launch preparation officially begins. Once Phase III begins, your evidence ...

Belite Bio completes enrollment in phase 2/3 DRAGON II clinical trial evaluating tinlarebant for the treatment of Stargardt ...

The Phase 1 clinical study is expected to enroll approximately 24 healthy adult volunteers. The primary objectives of the study are to characterize the pharmacokinetic release profile of the nalmefene ...

Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular, immunological and fibrotic diseases, today announced outcomes from its Type C meeting with ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Maze Therapeutics, a clinical-stage biopharmaceutical company, announced the dosing of the first patient in its Phase 2 clinical trial, the HORIZON Study, which is investigating MZE829, an oral APOL1 ...

• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”),the six-month radiographic ...

BOULDER, Colo.--(BUSINESS WIRE)--Crestone, Inc. (“Crestone”) today announced positive topline results from the Phase 2 clinical trial evaluating CRS3123 in patients with Clostridioides difficile ...

Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027. Data from the ongoing parallel BROADEN2 Phase 2b atopic dermatitis trial is expected to be rep ...

Glioblastoma clinical trials are abundant, including one new drug combination showing promise.